Results 261 to 270 of about 21,171,014 (388)

Living with Haemophilia [PDF]

, 1996
Reem Al‐Sudairy
openalex   +1 more source

Chimeric Antigen Receptor T‐Cell Therapy: More Than an Anti‐Cancer Drug

HLA, Volume 107, Issue 1, January 2026.
ABSTRACT Initially, chimeric antigen receptor (CAR) T‐cell therapy was developed to eliminate malignant B cells in haematological B‐cell malignancies by targeting CD19 and B‐cell maturation antigen. This approach achieved notable success, resulting in (malignant) B‐cell depletion and inducing clinical remission in cancer patients.
Hannah C. M. Schenk, Ilse Gille, Carolt Arana, Jordi Rovira, Eduard Palou, Fritz Diekmann, Dave L. Roelen, Mirjam H. M. Heemskerk, Sebastiaan Heidt   +8 more
wiley   +1 more source

Dental Management for People With Congenital Haemophilia: A Systematic Review of the Existing Dental Recommendations. [PDF]

Haemophilia
Kumar M, Badagabettu S, Pai KM, Angelitta Noronha J, Nayak BS, McCarthy P.   +5 more
europepmc   +1 more source

Detection of known haemophilia B mutations and carrier testing by microarray [PDF]

, 2005
Kaimin Chan, Werasak Sasanakul, Gillian Mellars, Ampaiwan Chuansumrit, David J. Perry, Christine A. Lee, Man-Sim Wong, T. P. T. Chan, Vivian Chan   +8 more
openalex   +1 more source

A Case Report of Non‐Neutralizing Acquired Factor V Inhibitor Mimicking Deficiency: Diagnostic Challenges and Therapeutic Implications

Case Reports in Hematology, Volume 2026, Issue 1, 2026.
Acquired Factor V (FV) deficiency due to inhibitors is a rare coagulopathy that presents significant diagnostic and therapeutic challenges. We report the case of an 81‐year‐old male with persistent gross hematuria and severe coagulopathy, marked by prolonged prothrombin time (PT), activated partial thromboplastin time (aPTT), and critically low FV ...
Shreyas Kalantri, Pranali Pachika, Shiva Balasubramanian, Bayan Alquran, Morgan McCoy, Vivek Sharma, Andrew Song   +6 more
wiley   +1 more source

Real-World Use of Extended Half-Life Factor IX in Children with Haemophilia B. [PDF]

Life (Basel)
Dettoraki A, Michalopoulou A, Saslis S, Dakou K, Stamati I, Thymianou S, Kapsimali Z, Papakonstantinou O, Pergantou H.   +8 more
europepmc   +1 more source

The Use of Tranexamic Acid to Treat Melasma: A Systematic Review and Meta‐Analysis

Dermatologic Therapy, Volume 2026, Issue 1, 2026.
Introduction Tranexamic acid (TXA) is a synthetic derivative of the amino acid lysine that inhibits bleeding due to its effects on plasminogen conversion, approved by the FDA to treat menorrhagia and prevent bleeding in hemophilia patients undergoing dental extraction.
Nabila Scabine Pessotti, Vinicius Tassoni Civile, Talita Andrade Brandao, Felipe Ribeiro, Gisele Viana de Oliveira, Nathalia Sernizon Guimarães, Denise Steiner, Mahlatse Kgokolo   +7 more
wiley   +1 more source

Emicizumab prophylaxis in current haemophilia A care in the Czech Republic-data from the Czech National Haemophilia Programme Registry. [PDF]

Res Pract Thromb Haemost
Zápotocká E, Ovesná P, Blažek B, Čermáková Z, Hajšmanová Z, Hrdličková R, Birke P, Procházková D, Smejkal P, Blatný J, Czech National Haemophilia Programme.   +10 more
europepmc   +1 more source

A Systematic Review of Modelling Approaches in Economic Evaluations of Treatments for Inherited Bleeding Disorders. [PDF]

Appl Health Econ Health Policy
Prameyllawati DM, Lingsma HF, Cnossen MH, Ten Ham RMT.   +3 more
europepmc   +1 more source

Human liver enzyme pattern in thyrotoxicosis and hypothyrodism [PDF]

, 1970
Bachmaier, B., Kiefhaber, P., Nolte, J., Pette, D., Scriba, Peter Christian   +4 more
core